Marksans Pharma said the Loperamide Hydrochloride tablet is an anti-diarrheal medication used to control symptoms of acute ...

Aptose Biosciences (OTC:APTOF) and its longtime partner, Hanmi Pharmaceutical Co. Ltd., announced a definitive arrangement agreement under which a Hanmi subsidiary will acquire the remaining ...

ORLANDO, FL / ACCESS Newswire / November 14, 2025 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today congratulated its ...

The FDA approval of the siRNA drug Redemplo caps off a tumultuous 12 months for Arrowhead, whose partnership with Sarepta caused its own stock to drop during the gene therapy maker’s safety troubles ...

Drugmakers are making notable deals, biotech is coming back, and much of the worry about tariffs and interest rates has faded ...

The next generation of weight loss drugs will hit the market in 2026. Eli Lilly and Novo Nordisk are racing to the finish ...

Zentalis Pharmaceuticals, Inc. focuses on developing azenosertib with a pivotal Denali Phase 2 trial underway. Learn more ...

Follow along for live updates on the Dow, S&P 500, Nasdaq and other markets.

You've disabled cookies in your web browser. A third-party browser plugin, such as Ghostery or NoScript, is preventing ...

OLMA stock surged 197% after Roche’s SERD breakthrough, signaling investor conviction in the future of ER-positive breast ...

Olema Pharmaceuticals stock surged 197% after Roche reported positive trial results for a similar breast cancer drug.

Now, it’s worth noting Stock Advisor’s total average return is 1,035% — a market-crushing outperformance compared to 191 % ...